newsfilter
← Latest News
PR Newswire·

Q BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancer

NEW YORK, March 16, 2022 /PRNewswire/ -- Q BioMed, Inc. (OTCQB:QBIO) a commercial-stage biotechnology development company announces a new publication supporting the efficacy and further development of its Uttroside B chemotherapeutic to treat liver canc